Gene name:
Phlpp1 (Kiaa0606;Phlpp;Plekhe1;Scop) ;
Protein name:
PH domain leucine-rich repeat-containing protein phosphatase 1 ;
Alternative:
Suprachiasmatic nucleus circadian oscillatory protein ;Pleckstrin homology domain-containing family E member 1 (PH domain-containing family E member 1) ;
Organism:
Mouse (Mus musculus).
General Annotation
Sub Unit:
Interacts with the nucleotide free form of K-Ras (KRAS) via its LRR repeats. Interacts with AKT2, AKT3 and PRKCB.
Function:
Protein phosphatase that mediates dephosphorylation of 'Ser-473' of AKT1, 'Ser-660' of PRKCB, and 'Ser-657' of PRKCA. AKT1 regulates the balance between cell survival and apoptosis through a cascade that primarily alters the function of transcription factors that regulate pro- and antiapoptotic genes. Dephosphorylation of 'Ser-473' of AKT1 triggers apoptosis and suppression of tumor growth. Controls the phosphorylation of AKT2 and AKT3 more efficiently than that of AKT1. Dephosphorylation of PRKCA and PRKCB leads to their destabilization and degradation. May act as a negative regulator of K-Ras signaling in membrane rafts.
Subcellular Location:
Cytoplasm
Membrane
Peripheral membrane protein
Nucleus
Protein Attributes:
50:
MEPAAAAPAQ | RLADPTGEDQ | ALAAAAAEGG | RCPDPALSAA | APSGGNGGAA |
100:
REEAPCEAPP | GPLPGRAGGT | GRRRRRGAPQ | PAAGGAAPVP | AAGGGANSLL |
150:
LKRGRLKRNL | SAAAAASSSS | SPSSASSAAG | GLPASCSASA | SLCTRSLDRK |
200:
TLLLKHRQLL | QLQPSDRDWV | RHQLQRGCVH | VFDRHMASSY | LRPVLCTLDT |
250:
TAAEVAARLL | QLGHKGGGVV | KVLGYGPPPA | AAPAASDQTL | DGEHGRDVEP |
300:
PPSSGTVGAV | RGPARAPPAD | LPLPGGAWTR | CAPRISPAPS | DSSPGELFAG |
350:
GPGSPPRAPR | PASDTESFSL | SPSAESVSDR | LDPYSSGGGG | SSSSSEELEA |
400:
DPAMPHRPGR | PAQPRPPSPK | TSALLQPKAP | TGVDSTGVIA | GEGPGDDKAM |
450:
AAAAPDVPLS | TSGRIRETVQ | KTSPPSLYVQ | LHGETTRRLE | ADEKPLQIQN |
500:
DYLFQLGFGE | LWRVQEEGMD | SEIGCLIRFY | AGKPHSTGSS | ERIQLSGMYN |
550:
VRKGKMQLPV | NRWTRRQVIL | CGTCLIVSSV | KDSVSGKMHV | LPLIGGKVEE |
600:
VKKHQHCLAF | SSSGPQSQTY | YICFDTFTEY | LRWLRQVSKV | ASQRISSVDL |
650:
SCCSLEHLPA | NLFYSQDLTH | LNLKQNFLRQ | TPTLPAARGL | GELQRFTKLK |
700:
SLNLSNNHLG | AFPSAVCSIP | TLAELNVSCN | ALREVPAAVG | DMQNLQTFLL |
750:
DGNFLQSLPA | ELESMHQLSY | LGLSFNEFTD | IPEVLEKLTA | VDKLCMAGNC |
800:
VETLRLQALR | RMPHIKHVDL | RLNILRKLMA | DEVDFVQHVT | QLDLRDNKLG |
850:
DLDAMIFNNI | EVLHCERNQL | VTLNVCGYFL | KALYASSNEL | AQLDVYPVPN |
900:
YLSYMDVSRN | CLESVPEWVC | ESRKLEVLDI | GHNQICELPA | RLFCNSSLRK |
950:
LLAGHNRLAR | LPERLERTSV | EVLDVQHNQI | TELPPNLLMK | ADSLRFLNAS |
1000:
ANKLETLPPA | TLSEETSSIL | QELYLTNNCL | TDKCVPLLTG | HPRLKILHMA |
1050:
YNRLQSFPAS | KMAKLEELEE | IDISGNKLKA | IPTTIMNCRR | MHTVIAHSNC |
1100:
IEVFPEVMQL | PEVKCVDLSC | NELSEITLPE | NLPPKLQELD | LTGNPRLALD |
1150:
HKSLELLNNI | RCFKIDQPSA | GDASGAPAVW | SHGYTEASGV | KNKLCVAALS |
1200:
VNNFRDNREA | LYGVFDGDRN | VEVPYLLQCT | MSDILAEELQ | KTKNEEEYMV |
1250:
NTFIVMQRKL | GTAGQKLGGA | AVLCHIKPDP | VDLGGSFTLT | SANVGKCQTV |
1300:
LCRNGKPLSL | SRSYIMSCEE | ERKRIKQHKA | IITEDGKVNG | VTESTRILGY |
1350:
TFLHPSVVPR | PHVQSVLLTP | QDEFFILGSK | GLWDSLSIDE | AVEAVRNVPD |
1400:
ALAAAKKLCT | LAQSYGCHDS | ISAVVVQLSV | TEDSFCCCEL | SAGGSMPPPS |
1450:
PGIFPPSVNM | VIKDRPSDGL | GVPSSSSGMA | SEISSELSTS | EMSSEVGSTA |
1500:
SDEPPSGVLN | ESSPAYPNEQ | RCMLHPVCLS | NSFQRQLSSA | TFSSAFSDNG |
1550:
LDSDDEEPIE | GVFSNGSRVE | VEVDIHCSRA | KEKERQQHLL | QVPAEASDEG |
1600:
IVISANEDES | GLSKKADFSA | VGTIGRRRAN | GSVAPQERSH | NVIEVAADAP |
1650:
LRKPGGYFAA | PAQPDPDDQF | IIPPELEEEV | KEIMKHHQEQ | QQQQQQQQLP |
1687:
PPPQPPQPQP | QPQPQPQPQP | QRHFQMDHLP | DCYDTPL
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Mouse
Human
Rat
ELISA Kit for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
ELISA Kit for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
ELISA Kit for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
CLIA Kit for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
CLIA Kit for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
CLIA Kit for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
Polyclonal Antibody for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
Polyclonal Antibody for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
Polyclonal Antibody for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
Monoclonal Antibody for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
Monoclonal Antibody for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
Monoclonal Antibody for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
Protein for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
Protein for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
Protein for Mouse PH domain leucine-rich repeat-containing protein phosphatase 1
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
References
1.
"Lineage-specific biology revealed by a finished genome assembly of the mouse."
Church D.M.
,
Goodstadt L.
,
Hillier L.W.
,
Zody M.C.
,
Goldstein S.
,
She X.
,
Bult C.J.
,
Agarwala R.
,
Cherry J.L.
,
DiCuccio M.
,
Hlavina W.
,
Kapustin Y.
,
Meric P.
,
Maglott D.
,
Birtle Z.
,
Marques A.C.
,
Graves T.
,
Zhou S.
,
Teague B.
,
Potamousis K.
,
Churas C.
,
Place M.
,
Herschleb J.
,
Runnheim R.
,
Forrest D.
,
Amos-Landgraf J.
,
Schwartz D.C.
,
Cheng Z.
,
Lindblad-Toh K.
,
Eichler E.E.
,
Ponting C.P.
more...
PLoS Biol.7:E1000112-E1000112(2009)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
strain :
C57BL/6J .
2.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 370-1687
tissue :
Brain .
3.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 424-1687
strain :
C57BL/6 .
strain :
Czech II .
strain :
FVB/N .
tissue :
Brain .
tissue :
Mammary tumor .
4.
"Changes in expression of the mouse homologues of KIAA genes after subchronic methamphetamine treatment."
Yamamoto H.
,
Imai K.
,
Takamatsu Y.
,
Kamegaya E.
,
Hara Y.
,
Shimada K.
,
Yamamoto T.
,
Shen H.W.
,
Hagino Y.
,
Kobayashi H.
,
Ide S.
,
Sora I.
,
Koga H.
,
Ikedaa K.
Ann. N. Y. Acad. Sci.1025:92-101(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INDUCTION